Eikon Therapeutics, Inc. (EIKN)
Nasdaq: EIKN · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2021
Who runs Eikon Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Perlmutter Roger M
Chief Executive Officer and Director. First filing Feb 2026, latest Mar 4, 2026, 0 filings in all.
Officers reporting now
5
of 11 people with a filing in the last fifteen months
Directors reporting now
6
11 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Perlmutter Roger M | Chief Executive Officer and Director | Feb 2026 | Mar 4, 2026 | none |
| Bowie Alfred Lloyd Jr. | Chief Financial Officer | Feb 2026 | Mar 4, 2026 | none |
| Klobuchar Michael A | Chief Operating Officer | Feb 2026 | Mar 4, 2026 | none |
| Baynes Roy D. | Chief Medical Officer | Feb 2026 | Mar 4, 2026 | none |
| Thorner Benjamin Bruno | General Counsel and Chief Business Officer | Feb 2026 | Mar 4, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Francisco Ma. Fatima | director | Jun 2026 | Jun 15, 2026 | none |
| Frazier Kenneth C | director | Feb 2026 | Mar 4, 2026 | none |
| Huffines Robert Luther | director | Feb 2026 | Mar 4, 2026 | none |
| Wolfe Josh | director | Feb 2026 | Feb 6, 2026 | none |
| Chen Leon | director | Feb 2026 | Feb 4, 2026 | none |
| Meline David W | director | Feb 2026 | Feb 4, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Column Group IV Gp, LP | 10% owner | Feb 2026 | Sep 8, 2026 | none |
| Column Group IV-A, LP | 10% owner | Feb 2026 | Sep 8, 2026 | none |
| Column Group IV, LP | 10% owner | Feb 2026 | Sep 8, 2026 | none |
| Column Group Opportunity III Gp, LP | 10% owner | Feb 2026 | Sep 8, 2026 | none |
| Column Group Opportunity III, LP | 10% owner | Feb 2026 | Sep 8, 2026 | none |
| Kutzkey Tim | 10% owner | Feb 2026 | Sep 8, 2026 | none |
| Svennilson Peter | 10% owner | Feb 2026 | Sep 8, 2026 | none |
| Tcg Opportunity III Gp, LLC | 10% owner | Feb 2026 | Sep 8, 2026 | none |
| Foresite Capital Fund IV, L.P. | 10% owner | Feb 2026 | Feb 6, 2026 | none |
| Foresite Capital Fund V, L.P. | 10% owner | Feb 2026 | Feb 6, 2026 | none |
| Foresite Capital Management IV, LLC | 10% owner | Feb 2026 | Feb 6, 2026 | none |
| Foresite Capital Management V, LLC | 10% owner | Feb 2026 | Feb 6, 2026 | none |
| Foresite Capital Opportunity Fund V, L.P. | 10% owner | Feb 2026 | Feb 6, 2026 | none |
| Foresite Capital Opportunity Management V, LLC | 10% owner | Feb 2026 | Feb 6, 2026 | none |
| Foresite Capital Vi-A Management, LLC | 10% owner | Feb 2026 | Feb 6, 2026 | none |
| Foresite Capital Vi-A, LLC | 10% owner | Feb 2026 | Feb 6, 2026 | none |
| Hebert Peter | 10% owner | Feb 2026 | Feb 6, 2026 | none |
| Lux Co-Invest Opportunities II, L.P. | 10% owner | Feb 2026 | Feb 6, 2026 | none |
| Lux Total Opportunities, L.P. | 10% owner | Feb 2026 | Feb 6, 2026 | none |
| Lux Venture Partners V, LLC | 10% owner | Feb 2026 | Feb 6, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.